CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know Posted byZacks Equity Research December 24, 2021 Leave a comment on CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $82.15, marking a +0.72% move from the previous day.